Cargando…

The advantages of UK Biobank's open‐access strategy for health research

Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximize the opportunities for scientific innovation and health improvements. Large‐scale population‐based prospective studies are particularly useful for multidisciplinary research into the...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, M., Sellors, J., Effingham, M., Littlejohns, T. J., Boultwood, C., Gillions, L., Sudlow, C. L. M., Collins, R., Allen, N. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790705/
https://www.ncbi.nlm.nih.gov/pubmed/31283063
http://dx.doi.org/10.1111/joim.12955
_version_ 1783458829009158144
author Conroy, M.
Sellors, J.
Effingham, M.
Littlejohns, T. J.
Boultwood, C.
Gillions, L.
Sudlow, C. L. M.
Collins, R.
Allen, N. E.
author_facet Conroy, M.
Sellors, J.
Effingham, M.
Littlejohns, T. J.
Boultwood, C.
Gillions, L.
Sudlow, C. L. M.
Collins, R.
Allen, N. E.
author_sort Conroy, M.
collection PubMed
description Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximize the opportunities for scientific innovation and health improvements. Large‐scale population‐based prospective studies are particularly useful for multidisciplinary research into the causes, treatment and prevention of many different diseases. UK Biobank has been established as an open‐access resource for public health research, with the intention of making the data as widely available as possible in an equitable and transparent manner. Access to UK Biobank's unique breadth of phenotypic and genetic data has attracted researchers worldwide from across academia and industry. As a consequence, it has enabled scientists to perform world‐leading collaborative research. Moreover, open access to an already deeply characterized cohort has encouraged both public and private sector investment in further enhancements to make UK Biobank an unparalleled resource for public health research and an exemplar for the development of open‐access approaches for other studies.
format Online
Article
Text
id pubmed-6790705
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67907052019-10-21 The advantages of UK Biobank's open‐access strategy for health research Conroy, M. Sellors, J. Effingham, M. Littlejohns, T. J. Boultwood, C. Gillions, L. Sudlow, C. L. M. Collins, R. Allen, N. E. J Intern Med Reviews Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximize the opportunities for scientific innovation and health improvements. Large‐scale population‐based prospective studies are particularly useful for multidisciplinary research into the causes, treatment and prevention of many different diseases. UK Biobank has been established as an open‐access resource for public health research, with the intention of making the data as widely available as possible in an equitable and transparent manner. Access to UK Biobank's unique breadth of phenotypic and genetic data has attracted researchers worldwide from across academia and industry. As a consequence, it has enabled scientists to perform world‐leading collaborative research. Moreover, open access to an already deeply characterized cohort has encouraged both public and private sector investment in further enhancements to make UK Biobank an unparalleled resource for public health research and an exemplar for the development of open‐access approaches for other studies. John Wiley and Sons Inc. 2019-08-02 2019-10 /pmc/articles/PMC6790705/ /pubmed/31283063 http://dx.doi.org/10.1111/joim.12955 Text en © 2019 The Authors. Journal of Internal Medicine published by John Wiley & Sons Ltd on behalf of Association for Publication of The Journal of Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Conroy, M.
Sellors, J.
Effingham, M.
Littlejohns, T. J.
Boultwood, C.
Gillions, L.
Sudlow, C. L. M.
Collins, R.
Allen, N. E.
The advantages of UK Biobank's open‐access strategy for health research
title The advantages of UK Biobank's open‐access strategy for health research
title_full The advantages of UK Biobank's open‐access strategy for health research
title_fullStr The advantages of UK Biobank's open‐access strategy for health research
title_full_unstemmed The advantages of UK Biobank's open‐access strategy for health research
title_short The advantages of UK Biobank's open‐access strategy for health research
title_sort advantages of uk biobank's open‐access strategy for health research
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790705/
https://www.ncbi.nlm.nih.gov/pubmed/31283063
http://dx.doi.org/10.1111/joim.12955
work_keys_str_mv AT conroym theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT sellorsj theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT effinghamm theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT littlejohnstj theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT boultwoodc theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT gillionsl theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT sudlowclm theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT collinsr theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT allenne theadvantagesofukbiobanksopenaccessstrategyforhealthresearch
AT conroym advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT sellorsj advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT effinghamm advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT littlejohnstj advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT boultwoodc advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT gillionsl advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT sudlowclm advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT collinsr advantagesofukbiobanksopenaccessstrategyforhealthresearch
AT allenne advantagesofukbiobanksopenaccessstrategyforhealthresearch